Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea · Delayed Price · Currency is KRW 10,350
+70 (0.68%)
Mar 13, 2026, 3:30 PM KST
Whan In Pharm Market Cap
Whan In Pharm has a market cap or net worth of 156.95 billion as of March 13, 2026. Its market cap has decreased by -10.92% in one year.
Market Cap
156.95B
Enterprise Value
98.02B
Revenue
256.32B
Ranking
n/a
PE Ratio
10.51
Stock Price
10,350.00
Market Cap Chart
Since June 24, 1997, Whan In Pharm's market cap has increased from 51.22B to 156.95B, an increase of 206.42%. That is a compound annual growth rate of 3.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 156.95B | -9.19% |
| Dec 30, 2025 | 172.82B | -4.15% |
| Dec 30, 2024 | 180.30B | -21.48% |
| Dec 28, 2023 | 229.62B | -14.55% |
| Dec 29, 2022 | 268.70B | -1.12% |
| Dec 30, 2021 | 271.75B | 6.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JW Lifescience | 200.37B |
| AptaBio Therapeutics | 193.84B |
| REYON Pharmaceutical | 191.30B |
| Daihan Pharmaceutical | 172.58B |
| SAMSUNG PHARM. Co., LTD. | 169.42B |
| Dongwha Pharm.Co.,Ltd | 167.97B |
| Hana Pharm | 166.00B |
| Ilsung Is | 160.29B |